DavidBMetzgerMD

PubMed

• Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074.
  Lancaster, K. E.,Miller, W. C.,Kiriazova, T.,Sarasvita, R.,Bui, Q.,Ha, T. V.,Dumchev, K.,Susami, H.,Hamilton, E. L.,Rose, S.,Hershow, R. B.,Go, V. F.,Metzger, D.,Hoffm...> ;AIDS Educ Prev. 2019 Mar 28
• Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
  Go, V. F.,Hershow, R. B.,Kiriazova, T.,Sarasvita, R.,Bui, Q.,Latkin, C. A.,Rose, S.,Hamilton, E.,Lancaster, K. E.,Metzger, D.,Hoffman, I. F.,Miller, W. C.> ;AIDS Behav. 2018 Oct 12
• Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
  Lancaster, K. E.,Hoffman, I. F.,Hanscom, B.,Ha, T. V.,Dumchev, K.,Susami, H.,Rose, S.,Go, V. F.,Reifeis, S. A.,Mollan, K. R.,Hudgens, M. G.,Piwowar-Manning, E. M.,Rich...> ;J Int AIDS Soc. 2018 Oct 24
• HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs.
  Fan Li, Liying Ma, Yi Feng, Yuhua Ruan, Jing Hu, Hongshuo Song, Pengtao Liu, Jun Ma, Baolin Rui, Kate Kerpen, Benjamin Scheinfeld, Tuhina Srivastava, David S. Metzger,...> ;AIDS. 2017 Nov 1
• Implementation of a Brief Treatment Counseling Toolkit in Federally Qualified Healthcare Centers: Patient and Clinician Utilization and Satisfaction.
  Brooks, A. C.,Chambers, J. E.,Lauby, J.,Byrne, E.,Carpenedo, C. M.,Benishek, L. A.,Medvin, R.,Metzger, D. S.,Kirby, K. C.> ;J Subst Abuse Treat. 2015 Oct 29
• 40 citations
  Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.
  Sandra A. Springer, Sarah Larney, Zahra Alammehrjerdi, Frederick L. Altice, David S. Metzger, Steven Shoptaw> ;Journal of Acquired Immune Deficiency Syndromes. 2015 Jun 1
• Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058.
  Metzger, D. S.,Donnell, D.,Celentano, D. D.,Jackson, J. B.,Shao, Y.,Aramrattana, A.,Wei, L.,Fu, L.,Ma, J.,Lucas, G. M.,Chawarski, M.,Ruan, Y.,Richardson, P.,Shin, K.,C...> ;J. Acquir. Immune Defic. Syndr.. 2015 Jan 08
• Innate Activation of MDC and NK Cells in High-risk HIV-1 Exposed, Sero-Negative (HESN) IV-Drug Users that Share Needles When Compared to Low-risk Non-sharing IV-Drug U...
  Tomescu, C.,Seaton, K. E.,Smith, P.,Taylor, M.,Tomaras, G. D.,Metzger, D. S.,Montaner, L. J.> ;J. Acquir. Immune Defic. Syndr.. 2014 Dec 17
• HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings From A Randomized Trial.
  Woody, G.,Bruce, D.,Korthuis, P. T.,Chhatre, S.,Hillhouse, M.,Jacobs, P.,Sorensen, J.,Saxon, A. J.,Poole, S.,Metzger, D.,Ling, W.> ;J. Acquir. Immune Defic. Syndr.. 2014 Sep 23
• Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and T...
  Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D> ;Drug Alcohol Depend. 2014-09-01
• Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer.
  Chhatre, S.,Metzger, D. S.,Malkowicz, S. B.,Woody, G.,Jayadevappa, R.> ;Cancer. 2014 Jul 22
• HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
  Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W> ;J. Acquir. Immune Defic. Syndr.. 2014-07-01
• Methadone maintenance for HIV positive and HIV negative patients in Kyiv: Acceptability and treatment response.
  Dvoriak, S.,Karachevsky, A.,Chhatre, S.,Booth, R.,Metzger, D.,Schumacher, J.,Chychula, N.,Pecoraro, A.,Woody, G.> ;Drug Alcohol Depend. 2014 Feb 20
• Behind the cascade: analyzing spatial patterns along the HIV care continuum.
  Eberhart, M. G.,Yehia, B. R.,Hillier, A.,Voytek, C. D.,Blank, M. B.,Frank, I.,Metzger, D. S.,Brady, K. A.> ;J. Acquir. Immune Defic. Syndr.. 2013 Oct 30
• The Social and Behavioral Sciences Research Network: Translational Research to Reduce Disparities in HIV.
  Blank, M. B.,Metzger, D. S.,Wingood, G. M.,Diclemente, R. J.> ;J. Acquir. Immune Defic. Syndr.. 2013 Jun 1
• A new paradigm for optimizing HIV intervention synergy: the role of interdependence in integrating HIV prevention interventions.
  Wingood GM, Rubtsova A, DiClemente RJ, Metzger D, Blank M> ;J. Acquir. Immune Defic. Syndr.. 2013-06-01
• Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks.
  Williams C, Eisenberg M, Becher J, Davis-Vogel A, Fiore D, Metzger D> ;J. Acquir. Immune Defic. Syndr.. 2013-06-01
• Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV.
  Chhatre, S.,Metzger, D. S.,Frank, I.,Boyer, J.,Thompson, E.,Nidich, S.,Montaner, L. J.,Jayadevappa, R.> ;AIDS Care. 2013 Oct
• Join now to see all

Lectures

• Must Have Endovascular Skills: Fundamentals Advanced Techniques and Complication Management 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• My Worst Complication Case That We Salvaged! 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Renal and Mesenteric Interventions: Tips and Tricks 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Endovascular Interventions from Head to Toe, Basic to Complex 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Great Debates in Vascular Intervention 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Join now to see all